MONTELUKAST SODIUM
- Product NDC
- 69844-075
- 11-digit product format
- 698440075
- Labeler code
- 69844
- Product ID
- 69844-075_b287c48f-bf1c-4830-ba9a-92c83f468448
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- MONTELUKAST SODIUM
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Labeler
- Graviti Pharmaceuticals Private Limited
- Application
- ANDA209011
- Marketing category
- ANDA
- Marketing start
- 2022-01-14
- Marketing end
- 0000-00-00
- Substance
- MONTELUKAST SODIUM
- Active strength
- 5 mg/1
- Pharmacologic classes
- Leukotriene Receptor Antagonist [EPC], Leukotriene Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69844-075-01 | 69844007501 | 30 TABLET, CHEWABLE in 1 BOTTLE (69844-075-01) | 2022-01-14 | 0000-00-00 | No | No | Current |
| 69844-075-02 | 69844007502 | 100 TABLET, CHEWABLE in 1 BOTTLE (69844-075-02) | 2022-01-14 | 0000-00-00 | No | No | Current |
| 69844-075-03 | 69844007503 | 90 TABLET, CHEWABLE in 1 BOTTLE (69844-075-03) | 2022-01-14 | 0000-00-00 | No | No | Current |